Work

Supplementary Table S8 from MIG6 Mediates Adaptive and Acquired Resistance to ALK/ROS1 Fusion Kinase Inhibition through EGFR Bypass Signaling

Year: 2024

Type: supplementary-materials

Abstract: IC50 values for ALK/ROS1 fusion-driven cell lines treated with fusion kinase inhibitors with and without afatinib combination.

DOI: 10.1158/1535-7163.24935391

Authors: Nan Chen, Logan C. Tyler, Anh T. Le, Eric A. Welsh, Bin Fang, Andrew Elliott, Kurtis D. Davies, Thomas Danhorn, Gregory J. Riely, Marc Ladanyi, Eric B. Haura, Robert C. Doebele

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4390539710

Cites:

Cited by:

Related to: 10